Cargando…
Pulmonary surfactant and COVID-19: A new synthesis
CHAPTER 1: COVID-19 pathogenesis poses paradoxes difficult to explain with traditional physiology. For instance, since type II pneumocytes are considered the primary cellular target of SARS-CoV-2; as these produce pulmonary surfactant (PS), the possibility that insufficient PS plays a role in COVID-...
Autores principales: | Ninham, Barry, Reines, Brandon, Battye, Matthew, Thomas, Paul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10411325/ https://www.ncbi.nlm.nih.gov/pubmed/37564950 http://dx.doi.org/10.1017/qrd.2022.1 |
Ejemplares similares
-
Pulmonary intravascular coagulopathy in COVID-19 pneumonia
por: Reines, Brandon P, et al.
Publicado: (2020) -
Nafion: New and Old Insights into Structure and Function
por: Ninham, Barry W., et al.
Publicado: (2023) -
Reduced levels of pulmonary surfactant in COVID-19 ARDS
por: Schousboe, Peter, et al.
Publicado: (2022) -
Assessment of pulmonary surfactant in COVID-19 patients
por: Schousboe, Peter, et al.
Publicado: (2020) -
Pulmonary surfactant as a versatile biomaterial to fight COVID-19
por: Herman, Lore, et al.
Publicado: (2022)